Rebamipide: evidence base for use in gastroenterology

Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and larg...

Full description

Bibliographic Details
Main Authors: D. N. Andreev, I. V. Maev
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2020-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/60263/43430
_version_ 1819119068490235904
author D. N. Andreev
I. V. Maev
author_facet D. N. Andreev
I. V. Maev
author_sort D. N. Andreev
collection DOAJ
description Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and large intestine.
first_indexed 2024-12-22T05:58:54Z
format Article
id doaj.art-561d1730411f4d18816408b3c8dfa9c9
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-22T05:58:54Z
publishDate 2020-12-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-561d1730411f4d18816408b3c8dfa9c92022-12-21T18:36:36Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422020-12-0192129710410.26442/00403660.2020.12.20045555198Rebamipide: evidence base for use in gastroenterologyD. N. Andreev0https://orcid.org/0000-0002-4007-7112I. V. Maev1https://orcid.org/0000-0001-6114-564XYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryRebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and large intestine.https://ter-arkhiv.ru/0040-3660/article/viewFile/60263/43430rebamipidegastroesophageal reflux diseasecorrosive esophagitisfunctional dyspepsiachronic gastritispeptic ulcer diseasehelicobacter pylorinsaid gastropathynsaid enteropathyulcerative colitis
spellingShingle D. N. Andreev
I. V. Maev
Rebamipide: evidence base for use in gastroenterology
Терапевтический архив
rebamipide
gastroesophageal reflux disease
corrosive esophagitis
functional dyspepsia
chronic gastritis
peptic ulcer disease
helicobacter pylori
nsaid gastropathy
nsaid enteropathy
ulcerative colitis
title Rebamipide: evidence base for use in gastroenterology
title_full Rebamipide: evidence base for use in gastroenterology
title_fullStr Rebamipide: evidence base for use in gastroenterology
title_full_unstemmed Rebamipide: evidence base for use in gastroenterology
title_short Rebamipide: evidence base for use in gastroenterology
title_sort rebamipide evidence base for use in gastroenterology
topic rebamipide
gastroesophageal reflux disease
corrosive esophagitis
functional dyspepsia
chronic gastritis
peptic ulcer disease
helicobacter pylori
nsaid gastropathy
nsaid enteropathy
ulcerative colitis
url https://ter-arkhiv.ru/0040-3660/article/viewFile/60263/43430
work_keys_str_mv AT dnandreev rebamipideevidencebaseforuseingastroenterology
AT ivmaev rebamipideevidencebaseforuseingastroenterology